Grade: Pharmaceutical Grade

Factory Location: JINAN

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Hyatrue^TM is a pharmaceutical grade sodium hyaluronate developed by Bloomage Freda Biopharm Co., Ltd., which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, in-articular injections, anti-adhesive preparations, topical preparations for wound healing and soft tissue filler ,etc. It includes Medical Grade Sodium Hyaluronate and Injection Grade Sodium Hyaluronate.

一、Advantages

1.High Safety

  (1)Bacteria and raw materials for fermentation are safe.

      Non animal sources: It is produced by bacterial fermentation. All the ingredients of medium are non animal sources.

      Non GMO: The strain is widely accepted as safe and is included in EP, JP, and China National Standard.

  (2)Products are safe

      Hyatrue^TM has been tested and proven safe and non toxic.

      Regulatory Compliance: Approved by the SFDA for sodium hyaluronate pharmaceutical excipient（F20040001）, sodium hyaluronate API（H20113379）, GMP Certificate（2010）, CEP Certificate, DMF, KDMF, passed  on-site audit by FDA and KFDA.

2.High Purity

     Product quality of Hyatrue^TM is much higher than European Pharmacopoeia standard and China National Standard, with much lower impurities.

     The endotoxin of Hyatrue^TM tested by Charles River is less than 0.0025IU/mg.

3.High Stability

     Stability tests were conducted to prove that Hyatrue's quality is stable under its recommended storage and transportation conditions.